Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Citinerz 250mg Injection

Prescription Icon
Prescription Required

Marketer

Zanetaz Medicorp

Salt Composition

Citicoline (250mg)

Overview Citinerz 250mg Injection

CerebralGuard 250mg Injection treats stroke, head trauma, Alzheimer's disease, and Parkinson's-related dementia by safeguarding and repairing brain cells, thus enhancing cognitive function. Administered intravenously by a healthcare professional only (when oral intake is infeasible), dosage and duration must follow physician instructions. Missed doses should be taken promptly upon recall. Potential side effects include hypotension, gastrointestinal upset (pain, diarrhea), cardiac arrhythmias, skin rash, sleep disturbances, and worsened numbness in affected limbs. Injection site reactions (pain, erythema, edema) may also occur, typically resolving spontaneously. Persistent or troublesome symptoms warrant medical consultation. Prior to treatment, disclose any kidney issues, seizure history (epilepsy), and current medications. Dosage is individualized based on age and diagnosis. Pregnant, breastfeeding, or intending to conceive patients should inform their physician before commencing treatment.

Uses of Citinerz 250mg Injection

Managing stroke, head trauma, Alzheimer's disease, and Parkinson's-related dementia.

Major Benefits of Citinerz 250mg Injection:

Administering this medication will be handled by your physician or their qualified nurse; self-medication is strongly discouraged.

Common Side effects of Citinerz 250mg Injection:

  • Injection site reactions (pain, swelling, redness)
  • Decreased blood pressure
  • Arrhythmia (irregular heartbeats)
  • Stomach pain
  • Diarrhea
  • Insomnia (difficulty in sleeping)
  • Rash
  • Peripheral neuropathy (tingling and numbness of feet and hand)

How to use Citinerz 250mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Citinerz 250mg Injection works:

Neuropathic support is provided by Citinerz 250mg Injection, which fosters nerve cell health. This medication enhances neuronal survival and shields against injury by stimulating production of key neurochemicals such as phosphatidylcholine and acetylcholine. Furthermore, it mitigates the accumulation of free fatty acids at nerve injury sites.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of alcohol with Citinerz 250mg Injection is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the use of Citinerz 250mg Injection in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Citinerz 250mg Injection with breastfeeding is absent. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Citinerz 250mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

For individuals with impaired kidney function, administration of Citinerz 250mg Injection requires careful monitoring. A modified dosage of Citinerz 250mg Injection might be necessary. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Citinerz 250mg Injection to individuals with hepatic impairment. Physician consultation is recommended.

What if you forget to take Citinerz 250mg Injection :

NA

Facts to Know About Citinerz 250mg Injection

LabelValue
Chemical Type Diphosphate Pyrimidine Ribonucleoside
Developing Habits No.
Treatment Category Neuroscience
Action Category Cognitive enhancer

FAQs on Citinerz 250mg Injection

Citinerz 250mg Injection delivers choline, a vital nutrient supporting brain health. It safeguards and repairs nerve cells, thus enhancing learning, memory, and cognitive function in individuals with Alzheimer's disease.
Because Citinerz 250mg Injection treats serious conditions like stroke and Alzheimer's disease, and its interaction with alcohol is unknown, alcohol consumption should be avoided.
Citinerz 250mg Injection is unsuitable for students. Research indicates its efficacy is limited to age-related memory impairment, post-stroke memory loss, and Alzheimer's disease. Its use in children is unsupported by evidence.
For stroke patients with blood clots, oral Citinerz 250mg Injection may facilitate full recovery within three months. Intravenous administration of Citinerz 250mg Injection within 12 hours of a stroke, or daily for seven days post-stroke, may accelerate recovery.
Citinerz 250mg Injection
111
MRP 129
13% off